US Broker Ratings

Phreesia, Inc. (PHR) Stock Analysis: A Healthcare Tech Play with 131.72% Upside Potential

Phreesia, Inc. (PHR), a prominent player in the healthcare technology sector, presents an intriguing investment opportunity with an impressive potential upside of 131.72%. As the company..

Ocular Therapeutix (OCUL) Stock Analysis: A Biotech Gem with 171% Upside Potential

Investors looking for high-growth opportunities in the biotechnology sector should keep an eye on Ocular Therapeutix, Inc. (NASDAQ: OCUL). This Massachusetts-based biopharmaceutical company is pioneering treatments..

Structure Therapeutics Inc. (GPCR) Stock Analysis: A 36.58% Potential Upside in Biotechnology

Structure Therapeutics Inc. (NASDAQ: GPCR) is making waves in the biotechnology sector with its promising pipeline of novel therapeutics targeting chronic diseases. As a clinical-stage biopharmaceutical..

Biohaven Ltd. (BHVN): Analyst Consensus Points to 63% Upside Potential Amidst Biotech Innovation

Biohaven Ltd. (BHVN), a prominent player in the biotechnology sector, has been making headlines with its promising pipeline of therapies targeting a range of neurological, immunological,..

Progyny, Inc. (PGNY) Stock Analysis: A 42.77% Potential Upside in the Fertility Benefits Sector

Progyny, Inc. (NASDAQ: PGNY) is carving out a distinct niche in the healthcare sector, specifically within the healthcare plans industry, by offering innovative fertility and family-building..

Neogen Corporation (NEOG) Stock Analysis: Navigating a Path Through Healthcare Diagnostics with a 9.96% Potential Upside

Neogen Corporation (NASDAQ: NEOG), a key player in the healthcare sector specializing in diagnostics and research, presents an intriguing opportunity for investors looking to tap into..

AtriCure, Inc. (ATRC) Stock Analysis: A 42.95% Potential Upside Beckons Investors

AtriCure, Inc. (NASDAQ: ATRC) is a noteworthy player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Mason, Ohio, AtriCure focuses..

Teladoc Health, Inc. (TDOC) Stock Analysis: Unlocking 79% Potential Upside in the Virtual Healthcare Space

Teladoc Health, Inc. (NYSE: TDOC) stands as a formidable player in the burgeoning virtual healthcare industry. Offering an expansive range of services through its Teladoc Health..

Tandem Diabetes Care, Inc. (TNDM): Investor Outlook with a 38.40% Potential Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is a standout player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $1.28..

Ligand Pharmaceuticals (LGND) Stock Analysis: Unlocking 30% Upside Potential with Robust Revenue Growth

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), a prominent player in the biotechnology sector, stands out with a market capitalization of $3.68 billion. Headquartered in Jupiter, Florida, the..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Exploring a Potential 75% Upside in the Biotech Sector

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a clinical-stage biotechnology company, is capturing investor interest with its innovative approach to drug discovery. By integrating cutting-edge technology in biology,..

Indivior Pharmaceuticals, Inc. (INDV) Investor Outlook: Navigating a 34.59% Potential Upside

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) is gaining attention among individual investors as it stands at the forefront of addressing one of the most pressing public health..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 55% Potential Upside Amidst Promising Growth

In the dynamic landscape of biotechnology, Vericel Corporation (NASDAQ: VCEL) has carved out a niche with its innovative cellular therapies and specialty biologic products. With a..

Belite Bio, Inc (BLTE) Stock Analysis: Biotechnology Innovator with 4.98% Potential Upside

Belite Bio, Inc (NASDAQ: BLTE), a burgeoning player in the biotechnology sector, is capturing investor attention with its promising drug pipeline and significant growth potential. As..

Artivion, Inc. (AORT) Stock Analysis: A 30.56% Potential Upside Ignites Investor Interest

Artivion, Inc. (NASDAQ: AORT), a prominent player in the healthcare sector specializing in medical devices, is catching the attention of investors with a compelling 30.56% potential..

Protagonist Therapeutics, Inc. (PTGX) Investor Outlook: Exploring a 22.32% Potential Upside Amidst Strong Buy Ratings

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is capturing investor attention with its strategic focus on developing peptide therapeutics targeting hematology and inflammatory diseases. As a prominent player..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: Biotech Innovator with 47.7% Upside Potential

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a key player in the biotechnology industry, is capturing the attention of investors with its innovative approach to drug development and..

Enovis Corporation (ENOV) Stock Analysis: Uncovering a 101.66% Potential Upside

Enovis Corporation (NYSE: ENOV), a pivotal player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for investors seeking exposure to the growing..

Ardent Health, Inc. (ARDT) Stock Analysis: Healthcare Giant with Potential 45% Upside

Ardent Health, Inc. (ARDT), a prominent player in the U.S. healthcare sector, is drawing considerable attention from investors thanks to its robust potential upside of 45.02%...

GRAIL, Inc. (GRAL) Stock Analysis: Healthcare Innovator with Potential 14.54% Upside

GRAIL, Inc. (GRAL) is making waves in the healthcare sector with its innovative approach to diagnostics and research. With a market capitalization of $3.91 billion, this..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds